Fine Foods & Pharmaceuticals N.T.M Balance Sheet Health
Financial Health criteria checks 5/6
Fine Foods & Pharmaceuticals N.T.M has a total shareholder equity of €130.5M and total debt of €56.4M, which brings its debt-to-equity ratio to 43.2%. Its total assets and total liabilities are €232.0M and €101.4M respectively. Fine Foods & Pharmaceuticals N.T.M's EBIT is €15.2M making its interest coverage ratio 4.7. It has cash and short-term investments of €9.1M.
Key information
43.2%
Debt to equity ratio
€56.44m
Debt
| Interest coverage ratio | 4.7x |
| Cash | €9.06m |
| Equity | €130.55m |
| Total liabilities | €101.41m |
| Total assets | €231.96m |
Recent financial health updates
Recent updates
Solid Earnings Reflect Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Strength As A Business
Sep 20
Is There An Opportunity With Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) 40% Undervaluation?
Apr 28Estimating The Fair Value Of Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF)
Mar 20Something To Consider Before Buying Fine Foods & Pharmaceuticals N.T.M. S.p.A. (BIT:FF) For The 1.1% Dividend
Feb 22A Look At Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Share Price Returns
Feb 01What You Need To Know About Fine Foods & Pharmaceuticals N.T.M. S.p.A.'s (BIT:FF) Investor Composition
Jan 14We Wouldn't Rely On Fine Foods & Pharmaceuticals N.T.M's (BIT:FF) Statutory Earnings As A Guide
Dec 28Is Fine Foods & Pharmaceuticals N.T.M (BIT:FF) Using Too Much Debt?
Dec 08Financial Position Analysis
Short Term Liabilities: FF's short term assets (€91.7M) exceed its short term liabilities (€62.3M).
Long Term Liabilities: FF's short term assets (€91.7M) exceed its long term liabilities (€39.2M).
Debt to Equity History and Analysis
Debt Level: FF's net debt to equity ratio (36.3%) is considered satisfactory.
Reducing Debt: FF's debt to equity ratio has increased from 21.1% to 43.2% over the past 5 years.
Debt Coverage: FF's debt is well covered by operating cash flow (74.1%).
Interest Coverage: FF's interest payments on its debt are well covered by EBIT (4.7x coverage).